A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients
Titel:
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients
Auteur:
Zinzani, P.L. Tani, M. Fanti, S. Stefoni, V. Musuraca, G. Castellucci, P. Marchi, E. Farsad, M. Fina, M. Pellegrini, C. Alinari, L. Derenzini, E. de Vivo, A. Bacci, F. Pileri, S. Baccarani, M.